| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1139/CJPP-2016-0741 |
| P698 | PubMed publication ID | 28679064 |
| P2093 | author name string | Pavel Babal | |
| Jan Slezak | |||
| Branislav Kura | |||
| P2860 | cites work | MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia | Q21092263 |
| Serum microRNAs are promising novel biomarkers | Q21144238 | ||
| MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? | Q21144444 | ||
| A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT | Q24306261 | ||
| Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions | Q24319987 | ||
| MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes | Q24604386 | ||
| Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice | Q24623247 | ||
| MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction | Q24648242 | ||
| MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes | Q24650009 | ||
| The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
| A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
| Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation | Q24679746 | ||
| MicroRNA and Heart Failure | Q26750638 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Radiation induced heart disease: Pathogenesis, management and review literature | Q26795690 | ||
| MicroRNA-target interactions: new insights from genome-wide approaches | Q27000642 | ||
| MicroRNA in radiotherapy: miRage or miRador? | Q27025405 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNAs in cardiovascular disease: an introduction for clinicians | Q28084229 | ||
| microRNAs: tiny regulators with great potential | Q28214699 | ||
| The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes | Q28241840 | ||
| MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy | Q28265961 | ||
| Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy | Q28273956 | ||
| miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
| Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy | Q28286000 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4 | Q28576826 | ||
| Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
| A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes | Q29616620 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR | Q33364667 | ||
| Mechanisms of cardiac radiation injury and potential preventive approaches | Q38510734 | ||
| MicroRNAs play an essential role in the development of cardiac hypertrophy | Q39340872 | ||
| Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases | Q39463484 | ||
| MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway | Q39560767 | ||
| Robust microRNA stability in degraded RNA preparations from human tissue and cell samples | Q39717005 | ||
| Radiation-induced heart disease: an update | Q40190659 | ||
| Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approaches | Q40222401 | ||
| On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs | Q40762827 | ||
| A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. | Q41844145 | ||
| Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease | Q45012180 | ||
| Myocardial connexin-43 and PKC signalling are involved in adaptation of the heart to irradiation-induced injury: Implication of miR-1 and miR-21. | Q53192065 | ||
| MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. | Q54631073 | ||
| miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. | Q54780999 | ||
| Ionizing radiation-induced oxidative stress alters miRNA expression | Q33487162 | ||
| MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes | Q33717662 | ||
| microRNAs in heart disease: putative novel therapeutic targets? | Q33728265 | ||
| MicroRNAs add a new dimension to cardiovascular disease | Q33761132 | ||
| Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection | Q33767975 | ||
| Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133 | Q33912698 | ||
| Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia | Q34032219 | ||
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 | ||
| MicroRNA sponges: progress and possibilities | Q34139023 | ||
| NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. | Q34504363 | ||
| Myogenic factors that regulate expression of muscle-specific microRNAs | Q34531532 | ||
| MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. | Q34644199 | ||
| Targeting microRNA expression to regulate angiogenesis | Q34722936 | ||
| Cardiac plasticity | Q34764732 | ||
| Pervasive roles of microRNAs in cardiovascular biology | Q34775686 | ||
| Plasma miR-208 as a biomarker of myocardial injury | Q34998594 | ||
| Biological response of cancer cells to radiation treatment | Q35600132 | ||
| Hypertrophy of the heart: a new therapeutic target? | Q35739349 | ||
| Inhibition of miR-15 protects against cardiac ischemic injury | Q35967093 | ||
| MicroRNA-21 in cardiovascular disease | Q36727758 | ||
| Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance | Q37045309 | ||
| Radiation-induced cardiovascular injury | Q37056377 | ||
| MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 | ||
| Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease | Q37685243 | ||
| Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury | Q37693239 | ||
| Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients | Q37815504 | ||
| Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy | Q37833232 | ||
| Protection of the heart against ischemia/reperfusion by silent information regulator 1. | Q38002171 | ||
| MicroRNAs: a new paradigm in the treatment and diagnosis of heart failure? | Q38021918 | ||
| Potential therapeutic role of microRNAs in ischemic heart disease. | Q38089400 | ||
| Biological consequences of radiation-induced DNA damage: relevance to radiotherapy | Q38121236 | ||
| MicroRNAs in heart failure: is the picture becoming less miRky? | Q38180696 | ||
| miRNA-1: functional roles and dysregulation in heart disease | Q38245253 | ||
| MicroRNAs: powerful regulators and potential diagnostic tools in cardiovascular disease | Q38265129 | ||
| P921 | main subject | microRNA | Q310899 |
| P577 | publication date | 2017-07-05 | |
| P1433 | published in | Canadian Journal of Physiology and Pharmacology | Q5030248 |
| P1476 | title | Implication of microRNAs in the development and potential treatment of radiation-induced heart disease |
| Q92493115 | A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress |
| Q54981115 | Irradiation-Induced Cardiac Connexin-43 and miR-21 Responses Are Hampered by Treatment with Atorvastatin and Aspirin. |
| Q92881879 | Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection |
| Q45064258 | Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury |
| Q94270413 | Protective effects of saponins in a rat model of severe acute pancreatitis occur through regulation of inflammatory pathway signaling by upregulation of miR-181b |
| Q52647444 | Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment. |
| Q90581263 | Radiation-induced heart disease: a review of classification, mechanism and prevention |
| Q64249406 | The Influence of Diet on MicroRNAs that Impact Cardiovascular Disease |
Search more.